Dongsung Chemical Co Ltd
Dongsung Chemical Co Ltd is a South Korean company engaged in the production and sale of commodity chemicals, primarily serving industrial and manufacturing sectors.
Business. Dongsung Chemical Co Ltd (102260.KS) is a South Korean company operating in the commodity chemicals industry within the basic materials sector. The firm is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Dongsung Chemical Co Ltd (102260.KS) is a South Korean company operating in the commodity chemicals industry within the basic materials sector. The firm is primarily listed on the Korea Exchange (KRX). Specific details regarding its operating segments and geographic revenue mix are not available.
Dongsung Chemical maintains a capital structure with a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position compared to industry norms. The company holds 106,357.52462 billion KRW in cash and equivalents, but this is offset by 151,973.75439 billion KRW in long-term debt, resulting in a net cash position of -45,616.22977 billion KRW. Free cash flow is negative at -8,002.45662 billion KRW, driven by capital expenditures of -29,311.48898 billion KRW, which suggests ongoing investment in operational capacity.
Profitability metrics show a return on equity (ROE) of 2.26% and a return on assets (ROA) of 0.91%, both below the industry median for commodity chemicals. The company's operating margin is 7.92% (calculated from operating income of 20,060.51051 billion KRW on revenue of 253,290.61992 billion KRW), which is modest but in line with the sector's cyclical nature.
Geographically, Dongsung Chemical's revenue is concentrated in South Korea, with no disclosed international segments. This concentration increases exposure to domestic economic conditions and regulatory shifts, particularly in the chemicals sector.
The company's growth trajectory is mixed. Revenue for the latest period is 253,290.61992 billion KRW, but no year-over-year growth rate is provided. Analysts estimate the trailing twelve months' earnings per share at 123.52 KRW. The outlook for the current fiscal year is neutral, with no significant directional guidance provided in the data.
Risk factors include medium liquidity risk due to negative net cash and a current ratio of 1.32, which is adequate but not robust. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. The company's capital structure remains stable, with no recent dilutive events reported.
Recent events include the filing of financial statements and the publication of analyst estimates. No material changes in business strategy or regulatory exposure were disclosed in the latest filings. The company continues to operate within the commodity chemicals segment, with no new product lines or geographic expansions noted.
- Dongsung Chemical maintains a conservative debt-to-equity ratio of 0.38, but its net cash position is negative due to high long-term debt.
- ROE and ROA are below industry medians, indicating suboptimal returns on equity and assets.
- Revenue is concentrated in South Korea, increasing exposure to domestic economic and regulatory risks.
- Free cash flow is negative, driven by significant capital expenditures, suggesting ongoing investment in operational capacity.
- Liquidity risk is moderate, with a current ratio of 1.32, but net cash is negative after subtracting total debt.
- Dilution risk is low, with no near-term pressure from share issuance or convertible debt.
Bull / Bear case
Generated · model-assistedOperating income surged 23.9% year-over-year to 105.4 billion KRW, demonstrating strong top-line operational leverage.
Free cash flow rebounded sharply by 199.4% to 28.9 billion KRW, indicating significant improvement in cash generation.
Cash conversion ratio of 1.54 outperforms the 1.1 cohort median, reflecting efficient translation of earnings into cash.
Revenue grew 13.6% year-over-year to 1.21 trillion KRW, showing robust expansion in total sales volume.
Return on equity of 2.3% lags the 3.6% cohort median, indicating inefficient use of shareholder capital.
Net margin of 3.5% falls below the 4.2% cohort median, suggesting weaker final profitability compared to peers.
Medium liquidity risk flags potential challenges in meeting short-term obligations or maintaining adequate cash reserves.
Medium credit risk indicates potential concerns regarding the company's ability to service its debt obligations.
In focus — financials by report
Revenue KRW 306.15B; Operating income KRW 27.64B.
- ▍Revenue KRW 306.15B
- ▍Operating income KRW 27.64B
- ▍Net margin 4.1%
Revenue KRW 254.52B; Operating income KRW 20.72B.
- ▍Revenue KRW 254.52B
- ▍Operating income KRW 20.72B
- ▍Net margin 2.3%
Revenue KRW 252.36B; Operating income KRW 16.65B.
- ▍Revenue KRW 252.36B
- ▍Operating income KRW 16.65B
- ▍Net margin 7.0%
Revenue KRW 253.29B; Operating income KRW 20.06B.
- ▍Revenue KRW 253.29B
- ▍Operating income KRW 20.06B
- ▍Net margin 3.5%
Revenue KRW 1.07T, +7,4% YoY; Operating income +17,5% YoY.
- ▍Revenue KRW 1.07T, +7,4% YoY
- ▍Operating income +17,5% YoY
- ▍Net income +34,4% YoY
- ▍Free cash flow −262,8% YoY
- ▍Net margin 4.2%
Revenue KRW 993.00B, −12,9% YoY; Operating income +31,8% YoY.
- ▍Revenue KRW 993.00B, −12,9% YoY
- ▍Operating income +31,8% YoY
- ▍Net income −4,5% YoY
- ▍Free cash flow −28,4% YoY
- ▍Net margin 3.4%
Revenue KRW 1.14T, +23,1% YoY; Operating income +9,8% YoY.
- ▍Revenue KRW 1.14T, +23,1% YoY
- ▍Operating income +9,8% YoY
- ▍Net income +95,6% YoY
- ▍Free cash flow +5,4% YoY
- ▍Net margin 3.1%
Revenue KRW 925.98B; Operating income KRW 50.03B.
- ▍Revenue KRW 925.98B
- ▍Operating income KRW 50.03B
- ▍Net margin 1.9%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Dongsung Chemical Co Ltd Market data — financials · 2026-05-26
- Dongsung Chemical Co Ltd Market data — analyst estimates · 2026-05-26